Assessment tool for establishing local pharmaceutical manufacturing in low‐ and middle‐income countries.

BUSINESS; HEALTH services accessibility; MARKETING; EVALUATION of medical care; PHARMACEUTICAL industry; QUALITY assurance; MANUFACTURING industries; DECISION making in clinical medicine; MIDDLE-income countries; LOW-income countries

Abstract: Objective: In many low‐ and middle‐income countries (LMICs), limited availability, substandard quality and high prices of pharmaceutical products lead to lack of access to essential medicines and poor health outcomes. Manufacturing pharmaceuticals in LMICs may improve access for patients while increasing the market size for manufacturers. Methods: We present a tool for assessment of local manufacturing feasibility of pharmaceuticals, intended for use among key stakeholders during the business development process. The tool consists of five domains: product selection and capacity, market sizing, market entry, funding and quality assurance. Key findings: The tool is intended to identify barriers and facilitators for local manufacturing and provide a roadmap for decision‐making across multiple stakeholders. A case study in Namibia identified key barriers and facilitators to successful manufacturing in that county. Conclusions: Careful consideration of feasibility and potential for success may lead to improved health for the populations of LMIC as well as significant market potential for pharmaceutical manufacturers. [ABSTRACT FROM AUTHOR]

Copyright of International Journal of Pharmacy Practice is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)